The AML-IRF7−/−-TGIF1 mice had lower levels of PB AML cells and a longer survival time than AML-IRF7−/−-MSCV mice after transplantation of an equal number of AML cells (Fig. 4D, E). This evidence concerns the gene TGIF1 and acute myeloid leukemia.